Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Remi_Barbier
|
| gptkbp:focusesOn |
pain management drugs
abuse-deterrent opioid formulations |
| gptkbp:foundedYear |
1998
|
| gptkbp:founder |
gptkb:Remi_Barbier
|
| gptkbp:headquartersLocation |
gptkb:Austin,_Texas,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pain Therapeutics, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Remoxy
|
| gptkbp:renamed |
Cassava Sciences, Inc.
|
| gptkbp:tradedOn |
NASDAQ: PTIE
|
| gptkbp:website |
https://www.cassavasciences.com/
|
| gptkbp:bfsParent |
gptkb:Cassava_Sciences
gptkb:Remi_Barbier |
| gptkbp:bfsLayer |
8
|